Navigation Links
Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida
Date:11/5/2008

ch phenomenon occurs and the resulting tissue and cellular effects.

Impacting disciplines from drug development and drug delivery to neuroscience, blood-brain barrier behavior, neurology and neurosurgery, this new understanding will have fundamental implications for the long-term functional treatment of neurological and neurodegenerative diseases. Using this enhanced understanding of the blood-brain barrier and the role of microbubbles, it may be possible to develop a noninvasive means of successfully delivering potent pharmacological agents to treat neurological and neurodegenerative diseases that are currently not treatable.

The talk, "Identifying the Inertial Cavitation Threshold in a Vessel Phantom Using Focused Ultrasound and Microbubbles" (2pBB6) by Yao-Sheng Tung, James Choi, Shougang Wang, Jameel Feshitan, Mark Borden and Elisa Konofagou is at 2:45 p.m. on Tuesday, November 11.


7) DETECTING A HUMAN SWIMMER

Protecting military ships, oil tankers and pipelines from terrorists wearing scuba gear requires a sonar system that can distinguish a human swimmer from rocks, buoys, fish, and other marine mammals. The Swimmer Detection Sonar Network (SDSN), developed by Scientific Solutions, Inc., does this with narrow sonar beams that cut out the clutter of a harbor environment.

The SDSN sonar beams are formed by parabolic reflectors, which also record the return echo. As many as 12 reflectors pointing in different directions can be mounted together as a node on a pier or bulkhead. The SDSN strategy is less expensive and more effective than other swimmer detection techniques that use phased arrays, says Peter Stein from Scientific Solutions. It also has the advantage of being modular, in that additional sonar nodes can easily be added to increase area coverage.

Stein and his colleagues have run multiple trials in harbors and found that SDSN has a near 100% probability of identifying human swimmers at
'/>"/>

Contact: Jason Bardi
jbardi@aip.org
301-209-3091
American Institute of Physics
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology news :

1. 156th Acoustical Society of America Meeting, Nov. 10-14, 2008 in Miami
2. At ACS national meeting, global initiative set to tackle water issues
3. Society for General Microbiology 161st Meeting, University of Edinburgh
4. Scripps Florida scientists awarded $1.5M to fight major water and food parasites
5. Floridas worm grunters collect bait worms by inadvertently imitating mole sounds
6. New studies find global warming will have significant economic impacts on Florida coasts
7. Florida researchers receive JDRF Excellence in Clinical Research Award
8. Fecal microorganisms inhabit sandy beaches of Florida
9. DHS Expands Biometrics-at-Sea Program to the Florida Straits
10. ASNTR 15th anniversary meeting to be held May 1-3 in Florida
11. New south Florida nursery to focus on staghorn corals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... 2015  Unchained Labs just can,t get enough ... Avid Nano. Avid Nano designs, develops and manufactures ... Also today, Unchained Labs UNcaged the ... use protein sizing system. The pUNk is a ... size, size distribution, aggregation population and molecular weight. ...
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
(Date:7/7/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... commerce market announces a revised version of one of its first ... air on CNBC in New York , ... San Francisco metro areas.    ... ability to replace all the cards in your wallet and keep ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... body's natural immune responses could be a target of future cancer ... of Medicine of the University of Southern California. , The ... of Pathology, is the first to identify how EphB4 ?a protein ... important aspect of this study is that ?if we turn the ...
... uncovered a new cellular secret that may explain how ... cancers that makes treatment especially difficult. If the mechanism ... can be understood well enough to manipulate it, new ... metastatic cancers. , Significance of the Mayo Clinic ...
... potentially powerful new therapy for treating diabetes, peripheral vascular ... and into animals by demonstrating it restores nerve and ... particularly important implications for the estimated 21 million Americans ... blood vessels. , The therapy involves netrins, a family ...
Cached Biology News:USC researchers investigate protein that protects tumors 2Mayo Clinic researchers discover cancer cells may move via wave stimulation 2Mayo Clinic researchers discover cancer cells may move via wave stimulation 3Proteins spur diabetic mice models to grow blood vessels, nerves 2
(Date:7/28/2015)... ZIONA, Israel , July ... (TASE:CLPT; OTC:CQPTY), a regenerative medicine company utilizing its ... today announced that Shomrat Shurtz has been appointed ... 2015.      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ... 25 years of experience in marketing, regulatory and ...
(Date:7/27/2015)... and FRANKLIN, Tenn. ... a privately-owned  premier provider of health care services ... in the U.S., today announced that its parent ... signed a definitive agreement with Medical Properties Trust, ... acquisition of Capella for $900 million in cash.  The transaction ...
(Date:7/27/2015)... ... 2015 , ... Production of high tenacity filament yarn of viscose rayon (excluding ... For instance, it surpassed the EUR 106 million mark (in value terms) in 2013, ... a major producer, while Italy is a key consumer. , The high tenacity ...
(Date:7/27/2015)... Research presented at the 2015 AACC Annual Meeting & ... led to a fingerprick Ebola test becoming the first ... approval from the World Health Organization (WHO). This test ... West Africa by identifying suspected Ebola ... and treat these patients much faster than is currently ...
Breaking Biology Technology:CollPlant Names Shomrat Shurtz Senior Director of Business Development 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3
... , Revamilast is a PDE4 inhibitor, under development for ... successfully completed pre-clinical trials and Phase I studies , Phase ... UK , , Glenmark has initiated global  Phase IIb ... unmet medical need as globally they are over 300 million Asthma ...
... QinetiQ North America today announced the results of its ... experiment, which studied the effects of microgravity on host ... results of this experiment showed both the plants and ... (Biological Research In a Canister) homes on the shuttle. ...
... Bharat Renewable Energy Ltd (BREL) , a joint-venture of ... a program with SG Biofuels (SGB) to ... production of biodiesel in India. The program,s ... high performing hybrid varieties of Jatropha adapted to unique ...
Cached Biology Technology:Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule 'Revamilast' 2Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule 'Revamilast' 3Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule 'Revamilast' 4QinetiQ North America Gains New Insights into Plant Growth and Sustainable Life Support on Final Shuttle Flight 2Bharat Renewable Energy Forms Alliance With SG Biofuels to Deploy Jatropha Hybrids for Biodiesel in India 2